The point you are missing is THIS. They are developing a drug that was abandoned by a major pharma as being not feasible financially to bring to market. There are other compounds that do a better job and already in use and trusted by practitioners. It is all smoke and mirrors. Geeez. Wake up and smell the manure.
News 
Market Data 
Discover 
